Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Subconjunctival methylprednisolone versus postoperative steroid eye drops after uncomplicated cataract surgery
2010-021061-72Phase 4Completed
- Sponsor
- Akademiska sjukhuset
- Start
- Jun 2010
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of methylprednisolone in cataract (2 arms), sponsored by Akademiska sjukhuset. Primary endpoints: Intraocular pressure increase, Postoperative intraocular inflammation control and 1 more. Started Jun 2010; status: completed.
02
Drugs
methylprednisolone
03
Conditions
cataract
Beyond the preview
Go deeper on 2010-021061-72.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-021061-72.